{
  "patientId": "PAT001-OVC-2025",
  "labResults": [
    {
      "category": "Tumor Markers",
      "tests": [
        {
          "testName": "CA-125",
          "unit": "U/mL",
          "referenceRange": "< 35 U/mL",
          "results": [
            {
              "date": "2024-01-15",
              "value": 1456,
              "flag": "H",
              "note": "At initial diagnosis"
            },
            {
              "date": "2024-02-20",
              "value": 985,
              "flag": "H",
              "note": "Post-surgery, pre-chemotherapy"
            },
            {
              "date": "2024-03-15",
              "value": 245,
              "flag": "H",
              "note": "After cycle 1 chemotherapy"
            },
            {
              "date": "2024-04-15",
              "value": 89,
              "flag": "H",
              "note": "After cycle 2"
            },
            {
              "date": "2024-05-15",
              "value": 42,
              "flag": "H",
              "note": "After cycle 3"
            },
            {
              "date": "2024-06-15",
              "value": 28,
              "flag": "Normal",
              "note": "After cycle 4 - normalized!"
            },
            {
              "date": "2024-07-15",
              "value": 24,
              "flag": "Normal",
              "note": "After cycle 5"
            },
            {
              "date": "2024-08-15",
              "value": 22,
              "flag": "Normal",
              "note": "After cycle 6 (final cycle)"
            },
            {
              "date": "2024-09-15",
              "value": 35,
              "flag": "Borderline",
              "note": "On olaparib maintenance"
            },
            {
              "date": "2024-10-01",
              "value": 145,
              "flag": "H",
              "note": "Rising - concerning for progression"
            },
            {
              "date": "2024-10-15",
              "value": 389,
              "flag": "H",
              "note": "Rapid rise - progression confirmed"
            },
            {
              "date": "2024-11-01",
              "value": 445,
              "flag": "H",
              "note": "Peak before 2nd line therapy"
            },
            {
              "date": "2024-11-20",
              "value": 398,
              "flag": "H",
              "note": "After 1 cycle pegylated liposomal doxorubicin"
            },
            {
              "date": "2024-12-18",
              "value": 352,
              "flag": "H",
              "note": "Slow decline - stable disease"
            },
            {
              "date": "2025-01-15",
              "value": 289,
              "flag": "H",
              "note": "Continued slow decline"
            }
          ]
        }
      ]
    },
    {
      "category": "Complete Blood Count (CBC)",
      "tests": [
        {
          "testName": "Hemoglobin",
          "unit": "g/dL",
          "referenceRange": "12.0-16.0",
          "latestResult": {
            "date": "2025-01-15",
            "value": 10.8,
            "flag": "L",
            "note": "Mild anemia from chemotherapy"
          }
        },
        {
          "testName": "White Blood Cells",
          "unit": "K/uL",
          "referenceRange": "4.0-11.0",
          "latestResult": {
            "date": "2025-01-15",
            "value": 5.2,
            "flag": "Normal"
          }
        },
        {
          "testName": "Neutrophils",
          "unit": "K/uL",
          "referenceRange": "2.0-7.0",
          "latestResult": {
            "date": "2025-01-15",
            "value": 3.1,
            "flag": "Normal"
          }
        },
        {
          "testName": "Platelets",
          "unit": "K/uL",
          "referenceRange": "150-400",
          "latestResult": {
            "date": "2025-01-15",
            "value": 198,
            "flag": "Normal"
          }
        }
      ]
    },
    {
      "category": "Comprehensive Metabolic Panel",
      "tests": [
        {
          "testName": "Creatinine",
          "unit": "mg/dL",
          "referenceRange": "0.6-1.2",
          "latestResult": {
            "date": "2025-01-15",
            "value": 0.9,
            "flag": "Normal"
          }
        },
        {
          "testName": "eGFR",
          "unit": "mL/min/1.73mÂ²",
          "referenceRange": "> 60",
          "latestResult": {
            "date": "2025-01-15",
            "value": 78,
            "flag": "Normal"
          }
        },
        {
          "testName": "ALT",
          "unit": "U/L",
          "referenceRange": "7-56",
          "latestResult": {
            "date": "2025-01-15",
            "value": 32,
            "flag": "Normal"
          }
        },
        {
          "testName": "AST",
          "unit": "U/L",
          "referenceRange": "10-40",
          "latestResult": {
            "date": "2025-01-15",
            "value": 28,
            "flag": "Normal"
          }
        },
        {
          "testName": "Albumin",
          "unit": "g/dL",
          "referenceRange": "3.5-5.5",
          "latestResult": {
            "date": "2025-01-15",
            "value": 3.8,
            "flag": "Normal"
          }
        }
      ]
    },
    {
      "category": "Coagulation",
      "tests": [
        {
          "testName": "INR",
          "unit": "ratio",
          "referenceRange": "0.9-1.1",
          "latestResult": {
            "date": "2025-01-15",
            "value": 1.0,
            "flag": "Normal"
          }
        }
      ]
    }
  ],
  "summary": {
    "ca125Trend": "Elevated at diagnosis (1456), normalized with first-line therapy (22), rapid rise indicating platinum-resistant progression (389), slow decline on second-line therapy (289)",
    "overallStatus": "Stable disease on current therapy, but CA-125 remains significantly elevated",
    "clinicalSignificance": "CA-125 trajectory demonstrates platinum resistance. Current slow decline suggests modest response to pegylated liposomal doxorubicin."
  }
}
